Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bristol-Myers Squibb (BMY – Research Report) and R......

Evercore ISI analyst Cory Kasimov maintained a Buy rating on Regeneron yesterday and set a price target of $875.00. The company’s shares closed yes......

In a report released today, Louise Chen from Scotiabank maintained a Hold rating on Regeneron, with a price target of $770.00. According to TipRank......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN – Research Report), Korro Bio (KRRO – Research Re......

Regeneron Pharmaceuticals (($REGN)) has held its Q4 earnings call. Read on for the main highlights of the call. Regeneron Earnings Call Strikes Con......

Citi analyst Geoff Meacham maintained a Buy rating on Regeneron today and set a price target of $900.00. Meacham covers the Healthcare sector, focu......

U.S. stocks finished the week mixed as gains in technology shares helped offset weakness in financial stocks and rising rate pressure. The Dow Jone......

Analysts fell to the sidelines weighing in on Becton Dickinson (BDX – Research Report) and Regeneron (REGN – Research Report) with neutral ratings,......

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron’s latest clinical update centers on a Phase 1 tria......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN – Research Report) and Ocugen (OCGN ......